Posted in | News | Copper | Mining Business

Fluor Helps Achieve First Production of Copper Concentrate at Anglo American’s Quellaveco Mine

Fluor Corporation FLR announced today that first production of copper concentrate has been achieved at Anglo American's Quellaveco project in Peru.

This press release features multimedia. View the full release here:

The first production of copper concentrate marks the beginning of testing the processing plant with ore and the ramping up of mining activities to demonstrate readiness for operations.

"This is a major milestone for Anglo American and its partner Mitsubishi Corporation as the project nears completion ahead of receiving final regulatory clearance for commercial operations to begin," said Tony Morgan, president of Fluor's Mining & Metals business. "As execution partners for this mega-project—a state-of-the-art, world-class facility—we are proud to serve as members of the team that helped produce copper in fewer than 4 years after the project was approved.

"The project was delivered on time and on budget during a global pandemic through the commitment and collaboration of many companies using a one-team approach that was supported by many local and regional companies," Morgan said.

Quellaveco is one of the five largest copper deposits in the world, located more than 3,000 meters (9,842 ft.) above sea level in the Moquegua region of southern Peru. When completed, the open pit mine will process 140,500 short tons (127,500 metric tons) per day of ore via conventional crushing, grinding and flotation technology to produce 330,500 short tons (300,000 metric tons) of copper equivalent on average per year over the first 10 years of operations.

The mine will increase Peru's copper production by approximately 10 percent and will provide 2,500 direct jobs while including local suppliers in the supply chain.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.